<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) <break/>or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">cell line (Homo sapiens; male)</td><td valign="top">Raji B lymphocyte cells (wild type)</td><td valign="top">DSMZ</td><td valign="top">DSMZ Cat# ACC-319; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0511">CVCL_0511</ext-link></td><td valign="top"/></tr><tr><td valign="top">cell line (Homo sapiens; male)</td><td valign="top">Raji B lymphocyte cells (CDK9<sup>as</sup>)</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Raji B cells were obtained from DSMZ Cat# ACC-319, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0511">CVCL_0511</ext-link>. Homozygous mutation of F103 at the CDK9 gene loci in Raji B cells was performed using the CRISPR-Cas9 system.</td></tr><tr><td valign="top">antibody</td><td valign="top">anti-CDK9</td><td valign="top">Santa Cruz, Dallas, TX USA</td><td valign="top">sc-484</td><td valign="top"/></tr><tr><td valign="top">antibody</td><td valign="top">anti-alpha-tubulin</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">DM1A</td><td valign="top"/></tr><tr><td valign="top">antibody</td><td valign="top">anti-Pol II (total, unphos&#160;+&#160;phos)</td><td valign="top">BIOZOL, Eching, Germany</td><td valign="top">MABI0601</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">CellTiter 96 AQueous One Solution Cell Proliferation Assay (MTS)</td><td valign="top">Promega, Madison, WI USA</td><td valign="top">G3582</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Plasmo Test Mycoplasma Detection Kit</td><td valign="top">InvivoGen, San Diego, CA USA</td><td valign="top">rep-pt1</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Ovation Universal RNA-Seq System</td><td valign="top">NuGEN, Leek, The Netherlands</td><td valign="top">0343&#8211;32</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">TruSeq Small RNA Library Prep Kit</td><td valign="top">Illumina, Massachusetts USA</td><td valign="top">RS-200&#8211;0012</td><td valign="top"/></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">CDK9as inhibitor; 1-NA-PP1</td><td valign="top">Calbiochem, EMD Millipore, Danvers, MA USA</td><td valign="top">529579</td><td valign="top">CAS 221243-82-9</td></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">Solvent control; DMSO</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">D8418</td><td valign="top"/></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">4-thiouracil (4sU)</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">T4509</td><td valign="top"/></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">empigen BB detergent</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">30326</td><td valign="top"/></tr></tbody></table></table-wrap>